114 related articles for article (PubMed ID: 29479048)
1. Generic selection criteria for safety and patient benefit [VII]: Comparing the physicochemical and pharmaceutical properties of brand-name and generic terbinafine hydrochloride cream.
Nozawa M; Goto M; Wada Y; Kumazawa M; Shimokawa KI; Ishii F
Drug Discov Ther; 2018 Mar; 12(1):16-20. PubMed ID: 29479048
[TBL] [Abstract][Full Text] [Related]
2. Criteria for the selection of switch OTC drugs based on patient benefits, efficacy, and safety [II]: Comparing the physicochemical and pharmaceutical properties of brand-name and switch OTC terbinafine hydrochloride cream.
Takata M; Wada Y; Iwasawa Y; Kumazawa M; Shimokawa KI; Ishii F
Drug Discov Ther; 2018; 12(4):248-253. PubMed ID: 30224597
[TBL] [Abstract][Full Text] [Related]
3. Generic selection criteria for safety and patient benefit [VIII]: Comparing the physicochemical and pharmaceutical properties of brand-name and generic diclofenac sodium tapes.
Nozawa M; Goto M; Wada Y; Yotsukura K; Gannichida A; Ishii F; Shimokawa KI
Drug Discov Ther; 2019 Jul; 13(3):150-156. PubMed ID: 31257355
[TBL] [Abstract][Full Text] [Related]
4. Generic Selection Criteria for Safety and Patient Benefit [IV] - Physicochemical and pharmaceutical properties of brand-name and generic ketoprofen tapes.
Wada Y; Kihara M; Nozawa M; Shimokawa K; Ishii F
Drug Discov Ther; 2015 Jun; 9(3):229-33. PubMed ID: 26193946
[TBL] [Abstract][Full Text] [Related]
5. Generic selection criteria for safety and patient benefit [IX]: Evaluation of "feeling of use" of sodium hyaluronate eye drops using the Haptic Skill Logger (HapLog
Goto M; Nozawa M; Wada Y; Shimokawa KI; Ishii F
Drug Discov Ther; 2020; 14(1):14-20. PubMed ID: 32147626
[TBL] [Abstract][Full Text] [Related]
6. Generic selection criteria for safety and patient benefit [V]: Comparing the pharmaceutical properties and patient usability of original and generic nasal spray containing ketotifen fumarate.
Wada Y; Ami S; Nozawa M; Goto M; Shimokawa K; Ishii F
Drug Discov Ther; 2016; 10(2):88-92. PubMed ID: 27210891
[TBL] [Abstract][Full Text] [Related]
7. Generic selection criteria for safety and patient benefit [VI]: Comparing the physicochemical and pharmaceutical properties of brand-name, generic, and OTC felbinac tapes.
Wada Y; Takaoka Y; Nozawa M; Goto M; Shimokawa KI; Ishii F
Drug Discov Ther; 2017 Jan; 10(6):300-306. PubMed ID: 27725574
[TBL] [Abstract][Full Text] [Related]
8. Generic selection criteria for safety and patient benefit [X]: Water-vapor permeability and peel force properties of brand-name and generic ketoprofen tapes.
Nozawa M; Goto M; Wada Y; Ishii F; Shimokawa KI
Drug Discov Ther; 2021 May; 15(2):87-92. PubMed ID: 33952778
[TBL] [Abstract][Full Text] [Related]
9. Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product.
Huvelle S; Godet M; Hecq JD; Gillet P; Jamart J; Galanti LM
Int J Pharm Compd; 2016; 20(4):347-350. PubMed ID: 28333681
[TBL] [Abstract][Full Text] [Related]
10. [Prediction of systemic exposure of ketoprofen tapes by in vitro release test and pharmacokinetic model analysis: comparison between brand-name and generic formulations].
Awa K; Satoh H; Hori S; Sawada Y
Yakugaku Zasshi; 2012; 132(1):135-44. PubMed ID: 22214588
[TBL] [Abstract][Full Text] [Related]
11. Generic versus brand-name North American topical glaucoma drops.
Mammo ZN; Flanagan JG; James DF; Trope GE
Can J Ophthalmol; 2012 Feb; 47(1):55-61. PubMed ID: 22333853
[TBL] [Abstract][Full Text] [Related]
12. Generic selection criteria for safety and patient benefit [Ⅻ]: Comparing the physicochemical and pharmaceutical properties of brand-name and generic tulobuterol tape.
Shimokawa KI; Yotsukura K; Nozawa M; Wada Y; Ishii F
Drug Discov Ther; 2024 Jan; 17(6):409-414. PubMed ID: 38044119
[TBL] [Abstract][Full Text] [Related]
13. [Questionnaire survey of patients comparing the usability of brand-name and generic ketoprofen tapes].
Saita A; Inoue A; Ishibashi H; Tominaga K; Hori S; Miki A; Ohtani H; Ono N; Sawada Y
Yakugaku Zasshi; 2008 May; 128(5):795-803. PubMed ID: 18451628
[TBL] [Abstract][Full Text] [Related]
14. Assessing equivalence of innovator and generic formulations of betamethasone dipropionate cream and ointment.
Sequira J; Berardi M; Chan TM; Letarte J; Malchow R; Pramanick B; Wolkoff HN
Clin Ther; 1991; 13(6):687-94. PubMed ID: 1790543
[TBL] [Abstract][Full Text] [Related]
15. Brand name versus generic warfarin: a systematic review of the literature.
Dentali F; Donadini MP; Clark N; Crowther MA; Garcia D; Hylek E; Witt DM; Ageno W;
Pharmacotherapy; 2011 Apr; 31(4):386-93. PubMed ID: 21449627
[TBL] [Abstract][Full Text] [Related]
16. Bioequivalence and in vitro antimicrobial activity between generic and brand-name levofloxacin.
Sun HY; Liao HW; Sheng MH; Tai HM; Kuo CH; Sheng WH
Diagn Microbiol Infect Dis; 2016 Jul; 85(3):347-351. PubMed ID: 27181716
[TBL] [Abstract][Full Text] [Related]
17. The comparison of brand-name and generic formulations of venlafaxine: a therapeutic drug monitoring analysis.
Unterecker S; Proft F; Riederer P; Lauer M; Deckert J; Pfuhlmann B
Ther Drug Monit; 2014 Apr; 36(2):269-72. PubMed ID: 24365982
[TBL] [Abstract][Full Text] [Related]
18. Intrapatient variation in antiepileptic drug plasma concentration after generic substitution vs stable brand-name drug regimens.
Contin M; Alberghini L; Candela C; Benini G; Riva R
Epilepsy Res; 2016 May; 122():79-83. PubMed ID: 26987080
[TBL] [Abstract][Full Text] [Related]
19. Converting patients from brand-name clozapine to generic clozapine.
Sajbel TA; Carter GW; Wiley RB
Ann Pharmacother; 2001 Mar; 35(3):281-4. PubMed ID: 11261523
[TBL] [Abstract][Full Text] [Related]
20. Switch-backs associated with generic drugs approved using product-specific determinations of therapeutic equivalence.
Gagne JJ; Polinski JM; Jiang W; Dutcher SK; Xie J; Lii J; Fulchino LA; Kesselheim AS
Pharmacoepidemiol Drug Saf; 2016 Aug; 25(8):944-52. PubMed ID: 27102378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
